Current status of basic and clinical research on metformin in endometrial cancer
10.3760/cma.j.cn371439-20200208-00053
- VernacularTitle:二甲双胍在子宫内膜癌中的基础与临床研究现状
- Author:
Xiaoling ZHAO
1
;
Weimin KONG
Author Information
1. 首都医科大学附属北京妇产医院妇瘤科 100006
- From:
Journal of International Oncology
2020;47(7):440-443
- CountryChina
- Language:Chinese
-
Abstract:
Endometrial cancer is one of the most common gynecological malignancies, which is closely related to metabolic syndrome such as diabetes mellitus. In recent years, epidemiological studies have found that metformin has a positive effect on the prevention and treatment of endometrial cancer, and a large number of basic and clinical studies have supported this theory, indicating that metformin may become the new treatment for patients with endometrial cancer, especially with advanced and recurrent endometrial cancer, and endometrial dysplasia.
